Auditor14 Nov 2026, 09:50 pm
Parmax Pharma Appoints Bakul V. Ganatra & Co as Internal Auditors
AI Summary
Parmax Pharma Ltd announced the appointment of M/s. Bakul V. Ganatra & Co, Chartered Accountants, as the Internal Auditor for the Financial Year 2026-2027. This decision was made during a Board of Directors meeting held on November 14, 2026. The Board also approved other key agendas including the shifting of the registered office from Gujarat to Maharashtra, enhancing borrowing limits to ₹50 crores, and altering the utilization terms of preferential issue proceeds, all subject to shareholder approval. The meeting commenced at 06:30 PM IST and concluded at 08:00 PM IST.
Key Highlights
- Internal auditors appointed for FY 2026-27.
- Registered office to shift from Gujarat to Maharashtra.
- Borrowing limits enhanced to ₹50 crores.
- Terms of preferential issue proceeds utilization to be varied.
- Shareholder approval required for key proposals.
Price Impact
More from PARMAX